Breaking News

Ancor Acquires WellSpring

Partners with Sentinel Capital and Yukon Capital for buyout

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ancor Capital Partners has acquired WellSpring Pharmaceutical, based in Sarasota, FL, and Toronto, ON. WellSpring manufactures and markets specialty prescription and OTC products in North America and also offers contract manufacturing through its production plant in Ontario. Ancor partnered with Sentinel Capital and Yukon Capital to complete the transaction. Financial terms were not disclosed. “WellSpring represents the 15th acquisition of a healthcare company for Ancor and combines our experie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters